PBI28 COST-EFFECTIVENESS OF CERTOLIZUMAB PEGOL FOR THE TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS IN GREECE

Autor: Gourzoulidis, G., Rigopoulos, D., Kountouris, V., Christou, P., Kiri, S., Tzanetakos, C.
Zdroj: In Value in Health November 2019 22 Supplement 3:S422-S422
Databáze: ScienceDirect